About Nexnos Pharma Limited
Data last updated:
Nexnos Pharma Limited is a public limited company based in Chittorgarh, Rajasthan, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 14 August 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24100RJ2007PLC024845. Its GSTIN is 08AAGCA4692M1Z5 (Rajasthan). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹1.91 Cr. It was formerly known as Asnani Brokers Private Limited. It is led by directors including Kamal Asnani and Vinod Asnani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 103 Pratap Nagar Sindhi Colony, Chittorgarh, Rajasthan, India – 312001.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.91 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.7 Cr (net margin 10%) and EBITDA of ₹5.16 Cr (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 248% over three years and 331% over five years.
As per MCA filings, the company has open charges of ₹12 Cr and satisfied charges of ₹12 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website asnanionline.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered Address103 Pratap Nagar Sindhi Colony, Chittorgarh, Rajasthan, India – 312001
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Name History of Nexnos Pharma Limited
Nexnos Pharma has undergone 2 name changes throughout its history. The company was previously known as Asnani Brokers Private Limited, and Nexnos Pharma Limited. The current legal name is Nexnos Pharma Limited.
| Company Name | Status |
|---|---|
| Nexnos Pharma Limited | Current |
| Asnani Brokers Private Limited | Previous |
CIN History of Nexnos Pharma Limited
Nexnos Pharma has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100RJ2007PLC024845, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100RJ2007PLC024845 | Current |
| U67120RJ2007PTC024845 | Previous |
| U74110RJ2007PTC024845 | Previous |
| U24100RJ2007PTC024845 | Previous |
Business Activity of Nexnos Pharma Limited
The main business activity of Nexnos Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Nexnos Pharma Limited
Nexnos Pharma has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Asnani | Director | 14 Aug 2007 | 19 Years 1 Months | Current |
| Vinod Asnani | Director | 14 Aug 2007 | 19 Years 1 Months | Current |
| Rajesh Peswani Also directs: Euro Exports Private Limited | Director | 20 Mar 2024 | 2 Years 6 Months | Current |
| Rameshchandra Also directs: Remescan Healthcare Private Limited | Director | 03 May 2023 | 3 Years 5 Months | Current |
| Ashish Kumar Agrawal | Director | 03 May 2023 | 3 Years 5 Months | Current |
Financials of Nexnos Pharma Limited FY 2025 filings available
Nexnos Pharma Limited reported revenue of ₹36.91 Cr (up 187.00% YoY) for FY 2025.
Growth of Nexnos Pharma Limited
| Metric | 1-year growth | 3-year compounded (CAGR) | 5-year compounded (CAGR) |
|---|---|---|---|
| Revenue | ▲ 187% | ▲ 248% | ▲ 331% |
| Net profit | ▲ 156% | ▲ 377% | ▲ 317% |
| EBITDA | ▲ 151% | ▲ 300% | ▲ 224% |
Revenue has grown at a compounded annual rate (CAGR) of 331% over five years, including 187% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nexnos Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.16 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.7 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nexnos Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nexnos Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nexnos Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2024 | Others | ₹12 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Nexnos Pharma Limited
Employment history and EPFO contributions of people linked to Nexnos Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Nexnos Pharma Limited
Nexnos Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAGCA4692M1Z5 | Rajasthan | Active | 01 Jul 2017 |
| 27AAGCA4692M1Z5 | Maharashtra | Active | 01 Jun 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Nexnos Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nexnos Pharma Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nexnos Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nexnos Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Nexnos Pharma Limited
Frequently Asked Questions about Nexnos Pharma Limited
Nexnos Pharma is an active public limited company based in Chittorgarh, Rajasthan, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 14 August 2007 (19+ years old) and is registered under CIN U24100RJ2007PLC024845.
Nexnos Pharma reported revenue of ₹36.91 Cr for FY 2025 (up 187.00% YoY).
Nexnos Pharma has 5 current directors:
- Kamal Asnani - Director
- Vinod Asnani - Director
- Rajesh Peswani - Director
- Rameshchandra - Director
- Ashish Kumar Agrawal - Director
Nexnos Pharma reported a net profit of ₹3.7 Cr (net margin 10%) and EBITDA of ₹5.16 Cr (EBITDA margin 14%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nexnos Pharma is 248% over three years and 331% over five years. In the latest year (FY 2025) revenue rose 187%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nexnos Pharma is 08AAGCA4692M1Z5, registered in Rajasthan. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAGCA4692M1Z5 (Maharashtra).
The CIN (Corporate Identification Number) of Nexnos Pharma is U24100RJ2007PLC024845. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nexnos Pharma was incorporated on 14 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Jaipur.
Nexnos Pharma can be reached through the website asnanionline.com. Its registered office is in Chittorgarh, Rajasthan, India.